ChemoCentryx Inc (NASDAQ:CCXI)

During the Trading Day
4.75 -0.01 / -0.21%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.75 0.00 / 0.00%
Volume: 5.6K
Health Technology

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. It was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:



Individual stakeholders48.43%
Other institutional36.88%
Mutual fund holders24.57%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
Susan M. KanayaCFO, Secretary & Head-Investor Relations
Petrus BekkerSenior Vice President-Medical & Clinical Affairs
Juan C. JaenChief Scientific Officer & SVP-Drug Discovery
Anne-Marie S. DuliegeChief Strategic Development Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.